摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Hypoxanthine, 9-(cis-3-(hydroxymethyl)cyclopentyl)- | 120330-37-2

中文名称
——
中文别名
——
英文名称
Hypoxanthine, 9-(cis-3-(hydroxymethyl)cyclopentyl)-
英文别名
9-[(1S,3R)-3-(hydroxymethyl)cyclopentyl]-1H-purin-6-one
Hypoxanthine, 9-(cis-3-(hydroxymethyl)cyclopentyl)-化学式
CAS
120330-37-2
化学式
C11H14N4O2
mdl
——
分子量
234.25
InChiKey
OWBYMOPAAVGKEM-SFYZADRCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    79.5
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Carboxylic purine nucleosides, their production and use
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0236935A2
    公开(公告)日:1987-09-16
    A compound of the formula: wherein R is a hydroxyl group which may be protected and Y is a purine base which may be protected, and the salts threof; which is useful as an antiviral agent.
    一种式如下的化合物 其中 R 是可被保护的羟基,Y 是可被保护的嘌呤基及其盐类;该化合物可用作抗病毒剂。
  • Cosmetic composition and the use thereof for regulating skin quality
    申请人:AchromaZ Pte. Ltd.
    公开号:US11123279B2
    公开(公告)日:2021-09-21
    The present invention relates to cosmetic or personal care compositions comprising two or more compounds, each compound containing an allylic or partially allylic carbonylsubstructure having the following structure I: wherein Y is a second substructure immediately adjacent to the allylic or partially allyliccarbonyl substructure and is selected from one of the following groups consisting of (i) hydroxyl-based group including —OH or —C(═)—(OH); (ii)carbonyl-based group including —C(═)—C (═O)—CH3; (iii) N ether group, —O—; (iv) sultam group, —N(H)—S(═O)2—; (v) lactam group, —N(H)—C(═O)—; (vi) apolar group including cyclic structures based on menthol or carotenoids; (vii) secondary aldimine containing group including —N(H)—C(NH2)═N— or —N(H)—C(H)═N—; (viii) amine group, —NH2; (ix) secondary amine-based group, —N(H)—; and (x) amide-based group including —N(H)—C(═O)— or —N(H)—C(═O)—N(H)—, their derivatives, isomers, salts and/or combination thereof; and a cosmetically acceptable vehicle.
    本发明涉及由两种或两种以上化合物组成的化妆品或个人护理组合物,每种化合物含有具有以下结构I的烯丙基或部分烯丙基羰基亚结构:其中 Y 是紧邻烯丙基或部分烯丙基羰基亚结构的第二个亚结构,选自下列基团之一 (i) 羟基基团,包括-OH 或-C(═)-(OH);(ii) 羰基基团,包括-C(═)-C(═O)-CH3; (iii) N 醚基团,-O-; (iv) 苏坦基团,-N(H)-S(═O)2-; (v) 内酰胺基团,-N(H)-C(═O)-;(v) 内酰胺基团,-N(H)-C(═O)-; (vi) 极性基团,包括基于薄荷醇或类胡萝卜素的环状结构; (vii) 含仲醛亚胺的基团,包括-N(H)-C(NH2)═N-或-N(H)-C(H)═N-; (viii) 氨基基团,-NH2;(x) 酰胺基团,包括-N(H)-C(═O)-或-N(H)-C(═O)-N(H)-,它们的衍生物、异构体、盐和/或它们的组合;以及化妆品可接受的载体。
  • A Cosmetic Composition and the Use Thereof for Regulating Skin Quality
    申请人:AchromaZ Pte. Ltd.
    公开号:US20190021974A1
    公开(公告)日:2019-01-24
    The present invention relates to cosmetic or personal care compositions comprising two or more compounds, each compound containing an allylic or partially allylic carbonyl substructure having the following structure I: wherein Y is a second substructure immediately adjacent to the allylic or partially allyliccarbonyl substructure and is selected from one of the following groups consisting of (i) hydroxyl-based group including —OH or —C(═)—(OH); (ii) carbonyl-based group including —C(═)—C (═O)—CH 3 ; (iii) ether group, —O—; (iv) sultam group, —N(H)—S(═O) 2 —; (v) lactam group, —N(H)—C(═O)—; (vi) apolar group including cyclic structures based on menthol or carotenoids; (vii) secondary aldimine containing group including —N(H)—C(NH 2 )═N— or —N(H)—C(H)═N—; (viii) amine group, —NH 2 ; (ix) secondary amine-based group, —N(H)—; and (x) amide-based group including —N(H)—C(═O)— or —N(H)—C(═O)—N(H)—, their derivatives, isomers, salts and/or combination thereof; and a cosmetically acceptable vehicle.
  • US4916224A
    申请人:——
    公开号:US4916224A
    公开(公告)日:1990-04-10
  • US4968674A
    申请人:——
    公开号:US4968674A
    公开(公告)日:1990-11-06
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦